Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production - Level 2 revision: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 16, 2022
August 1, 2024
1e06deea-ceb4-4e41-b2d2-1b4611f8ccdd
Related Documents
Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules
Guidance DocumentOctober 3, 2022Center for Drug Evaluation and Research
Control of Nitrosamine Impurities in Human Drugs: Guidance for Industry
Guidance DocumentSeptember 5, 2024Center for Drug Evaluation and Research
Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products: Guidance for Industry
Guidance DocumentJuly 29, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox